Financials
- Market Capitalization 7.59 M
- Employee 8
- Founded 2011
- CEO Paul Kang
- Website www.exicuretx.com
- Headquarter Delaware, United States
- FIGI BBG00GTJCSB4
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-6.86
ratio cours/chiffre d'affaires
—
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 4734 | TCRT Alaunos Therapeutics, Inc. - Common Stock | 3.03 USD | +188.57% | +309.46% | +103.36% | +13.52% | 7.70 M USD | ||
| 4735 | CURX Curanex Pharmaceuticals Inc - Common Stock | 4.88 USD | -8.10% | +1.88% | +10.66% | +674.60% | 7.65 M USD | ||
| 4740 | APRE Aprea Therapeutics, Inc. - Common Stock | 0.60 USD | +1.69% | -4.76% | -22.08% | -60.26% | 7.55 M USD | ||
| 4742 | SNGX Soligenix, Inc. - Common Stock | 0.33 USD | -5.71% | -8.33% | -10.81% | -70.80% | 7.18 M USD |